Vita Coco Trapped in Legal Binary: Costco Contract Risk Could Force Re-rating or Collapse

The catalyst is clear: a short report published on March 26, 2025, alleging Vita Coco was at risk of losing a key Costco contract accounting for about 25% of its sales. The market's immediate reaction was severe, with shares declining by $3.90 per share, or approximately 11% on that day. This single-day drop created a stark binary setup. The probe, initially launched by Kirby McInerney LLP, has since expanded, with multiple law firms including Schall Law and Pomerantz LLP now investigating potential securities fraud claims. This growing legal overhang has kept the stock in a state of heightened uncertainty.

The stock's subsequent trading pattern reveals a market already pricing in this volatility. Over the last five days, shares have rallied 5.45%, suggesting some relief or opportunistic buying. Yet over the last 20 days, the trend has been negative, with shares down 4.23%. This choppy range-gains on short-term optimism but losses on the medium-term view-highlights the stock's struggle to establish a clear direction amid the legal cloud. The setup is now a classic event-driven trade: the probe itself is the catalyst, and the market's reaction has been to swing violently between fear and hope, with the stock's recent volatility and elevated valuation multiples reflecting the high-stakes uncertainty.

The $90M Revenue Gap & Priced-In Risk

The core operational threat is quantifiable. The NINGI report alleges Vita Coco was at risk of losing a key Costco contract that accounted for about 25% of its sales. That's a potential $90 million annual revenue shortfall. For a company whose stock had been rallying on growth, this is a direct hit to the revenue engine. The market had been pricing in acceleration, but this risk suggests a core pillar of that story was already under strain.

Vita Coco has publicly dismissed the report as inaccurate, pointing to its own prior disclosures. The company cited its February 26, 2025, earnings call where it acknowledged inventory constraints and the expectation of losing some private label retailers in 2025. In other words, the company argues the specific contract risk was already in the public record. The probe now questions whether that disclosure was sufficient or if the company misled investors about the severity of the situation.

The market's prior reaction to the report is the critical data point. The stock did not collapse on March 26 when the report was published. Instead, it had already been on a powerful run, with shares climbing 12.8% over the last 120 days and posting an 85% rolling annual return. This creates a classic "priced-in" scenario. The market had already bet heavily on growth momentum, absorbing the warning without a major sell-off. The subsequent legal probes now introduce a new layer of uncertainty that wasn't in the model, creating a volatile dynamic where any news can swing sentiment sharply.

The bottom line is that the operational risk is real and material, but the market's prior growth narrative had already discounted a significant portion of it. The probe is a catalyst that forces a re-rating, but the direction depends entirely on whether the company's rebuttal holds up under legal scrutiny.

Valuation & Binary Setup

The current valuation is a direct reflection of the binary setup. Vita Coco trades at a forward EV/EBITDA of ~31.5 and a price-to-sales ratio of 4.6. These are premium multiples, built on the expectation of high growth. That narrative is now in question, creating a clear tension between the stock's rich valuation and the heightened legal and operational risks.

The 52-week high of $61.39 is over 25% above the current price. That gap is the primary upside catalyst. If the legal probes are resolved favorably-meaning the company successfully defends its disclosures and the Costco contract risk is mitigated-there is significant room for the stock to re-rate toward that high. The recent 5.45% rally over five days shows the market is already testing that optimistic path.

The primary risk, however, is a validation of the NINGI report's claims. A finding that the company misled investors about the $90 million revenue gap would trigger a deeper sell-off. It would force a complete reassessment of the growth story that underpins the current multiples. In that scenario, the stock's premium valuation would be unsustainable, and the path would be down toward the 52-week low of $29.74.

The bottom line is that the current price offers no margin of safety. It sits in a volatile middle ground, fully exposed to the binary outcome of the legal probe. The valuation is either a bet that the company wins the legal battle and growth resumes, or a bet that the probe fails and the premium multiples collapse. For now, the setup is purely event-driven, with the stock's fate hanging on the resolution of the investigations.

Near-Term Catalysts & Tactical Watchlist

For a stock trading on a binary setup, the tactical roadmap is clear. The next few weeks will be defined by specific events that will either dissipate the legal overhang or intensify the pressure. The market is waiting for concrete signals.

The first major catalyst is the potential filing of a formal securities class action lawsuit. While investigations are ongoing, the absence of a filed suit keeps the risk at a theoretical level. The involvement of multiple law firms, including Schall Law and Pomerantz LLP, increases the likelihood. A lawsuit would crystallize the legal risk, likely triggering a wave of volatility as the case's specifics and potential damages are debated. For now, the probe is a cloud; a lawsuit would make it a storm.

The next earnings report is a critical reset button. Vita Coco's Q1 results, expected in late May or early June, will provide the first hard data on whether the company is navigating the operational headwinds it acknowledged in February. Strong results that demonstrate resilience in core sales and a clear path to resolving inventory and private label issues could re-establish growth credibility. Conversely, any sign of further deterioration in the supply chain or private label business would validate the NINGI report's claims and likely trigger a deeper sell-off. This report is the operational counterpoint to the legal probe.

Finally, monitor for any new details or statements from the company regarding the Costco contract or supply chain. The company has publicly dismissed the report as inaccurate, citing its February 26, 2025, earnings call where it acknowledged inventory constraints and the expectation of losing some private label retailers. Any update that clarifies the status of that contract or provides new data on private label performance will be a direct test of the company's rebuttal. Silence or vague statements would keep the uncertainty high.

The bottom line is that the tactical watchlist is short and sharp. Watch for a lawsuit filing, the next earnings report, and any new operational disclosures. Each of these events will force a binary decision on the stock: either the legal and operational risks are contained, allowing the growth narrative to re-emerge, or they are confirmed, leading to a collapse in the premium valuation.